MCMRU - Overview: Mast Cell Mediators, Random, Urine

Evaluating patients at risk for mast cell activation syndrome (eg, systemic mastocytosis) using random urine collections

RPDEI - Overview: Rapidly Progressive Dementia Evaluation Interpretation, Spinal Fluid

Interpretation of the Rapidly Progressive Dementia Evaluation

RAPAN - Overview: Rheumatoid Arthritis Panel, Serum

Evaluating patients suspected of having rheumatoid arthritis (RA) Differentiating RA from other inflammatory arthritis or connective tissue diseases Diagnosis and stratification of rheumatoid arthritis

VWACT - Overview: von Willebrand Factor Activity, Plasma

Diagnosis of von Willebrand disease (VWD) and differentiation of VWD subtypes or differentiation of VWD from hemophilia A Monitoring therapeutic efficacy of treatment with DDAVP (desmopressin) or VWF concentrates in patients with VWD

2HGA - Overview: 2-Hydroxyglutaric Acid Chiral Analysis, Quantitative, Random, Urine

Determining type of 2-hydroxyglutaric aciduria by chiral analysis of urine

MSMRD - Overview: Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow

Risk stratification of patients with treated multiple myeloma, which can assist in determining treatment and management decisions Risk stratification of patients with newly diagnosed multiple myeloma

FAPIX - Overview: Apixaban, Plasma

Apixaban, Plasma

FAMBT - Overview: Amyloid Beta-Protein

Amyloid Beta-Protein

FCICP - Overview: Circulating Immune Complex Panel

Circulating Immune Complex Panel

FHBG - Overview: Hepatitis B Virus Genotyping

Hepatitis B Virus Genotyping